Skip to main content

Table 3 Univariate and multivariate logistic regression analysis for non-SLN metastasis

From: Association between postoperative pathological results and non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node-positive breast cancer

Exposure

Univariable

Multivariable

OR(95%CI)

P

OR(95%CI)

P

Age

 ≤ 50

1

 

1

 

 > 50

0.86 (0.54, 1.37)

0.5243

0.85 (0.36, 2.01)

0.7172

BMI

  ≤ 25

1

 

1

 

 > 25

0.79 (0.47, 1.33)

0.3786

0.73 (0.38, 1.40)

0.345

Tumor size (cm)

  ≤ 2

1

 

1

 

 > 2

1.93 (1.15, 3.22)

0.0126 *

1.22 (0.65, 2.27)

0.5308

Histological stage

 Negative

1

 

1

 

 Positive

0.65 (0.28, 1.54)

0.3275

1.21 (0.43, 3.39)

0.7196

Ki-67

 Negative

1

 

1

 

 Positive

1.34 (0.79, 2.28)

0.2774

1.05 (0.53, 2.11)

0.8822

HER2

 Negative

1

 

1

 

 Positive

2.05 (1.16, 3.63)

0.0134 *

2.25 (1.10, 4.60)

0.0269 *

ER

 Negative

1

 

1

 

 Positive

1.02 (0.54, 1.91)

0.9615

1.23 (0.40, 3.76)

0.7127

PR

 Negative

1

 

1

 

 Positive

1.05 (0.62, 1.78)

0.8612

1.29 (0.51, 3.26)

0.5919

LVI

 Negative

1

 

1

 

 Positive

6.11 (3.62, 10.32)

 < 0.0001 *

6.08 (3.31, 11.14)

 < 0.0001 *

Number SLNM

 1

1

 

1

 

  > 1

4.50 (2.72, 7.46)

 < 0.0001 *

4.17 (2.35, 7.42)

 < 0.0001 *

Menopause

 No

1

 

1

 

 Yes

0.96 (0.60, 1.55)

0.8742

1.69 (0.72, 4.00)

0.2296

  1. BMI body mass index, Number SLNM the number of sentinel lymph node metastases, HER2 human epidermal growth factor Receptor 2, ER estrogen receptor, PR progesterone receptor, LVI lymphovascular invasion
  2. *Statistically significant (p < 0.05)